SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies (BMNR) is generating significant buzz following its shareholder meeting, where the approval of a substantial increase in authorized shares and a strategic investment in a prominent content creator's company have sparked intense debate. The community is sharply divided, with many expressing concerns over potential dilution and the strategic rationale of the new investment, while others view these moves as a visionary play to expand reach and diversify beyond its core Ethereum holdings. This divergence in opinion, alongside the stock's performance relative to Ethereum, continues to fuel active discussion.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood ($HOOD) is seeing intense conversation following news of indefinitely delayed U.S. crypto legislation, which its CEO suggests negatively impacts American customers and has led to a significant stock decline. This, along with notices of planned future insider share sales, fuels bearish speculation about the company's valuation and near-term price action among some traders. However, a strong bullish contingent points to robust revenue growth and the booming success of prediction markets as key drivers, framing the current dip as a compelling buying opportunity.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile (ASTS) is soaring to new all-time highs, definitively closing above $100 for the first time, driven by reports of a recent satellite breakthrough. Long-term investors are celebrating this major milestone and anticipating further gains, contrasting sharply with persistent bearish sentiment challenging the pre-revenue valuation and potential need for more capital. Community dialogue highlights the critical need for ASTS's direct-to-cell satellite connectivity, underscored by recent telecom outages, and speculates on upcoming launches and government contract catalysts.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings Ltd (SPHL) is trending following an explosive price surge, driven by its ultra-low share float and strong short squeeze potential. The trading community is actively discussing substantial gains and comparing SPHL to other recent high-volatility micro-cap runners, alongside frustrations over some brokers restricting trading activity.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is trending following its recent 1-for-15 reverse stock split, which created an ultra-low share float. This has ignited significant community discussion and speculation about a potential short squeeze, drawing comparisons to other high-volatility, low-float runners like $SPHL. Despite some frustration over frequent trading halts, investors are actively discussing its potential for substantial upward price movement.

TryHard Holdings Ltd. is a lifestyle entertainment company that operates in Japan offering a diverse range of services across the entertainment and hospitality sectors. It operates through the following business segments: Consultancy and management, Event curation, Sub-leasing and Restaurants. The Consultancy and management segment provides expert services to clubs, including operations, event management, and strategic support to enhance performance and engagement. The Event curation segment organize and produce own events, also provides a full suite of services, including event planning, construction, entertainment booking, event operation, and ticket sales. The Sub-Leasing segment acts as an intermediary between landlords and clubs. The Restaurants segment operates several restaurants. The company was founded on October 16, 2013 and is headquartered in Osaka, Japan.

TryHard Holdings Ltd.

TryHard Holdings (THH) is actively trending as a recent IPO with significant volatility, fueled by announcements of a substantial equity purchase facility and a share repurchase program. The community is sharply divided, with many anticipating a major rebound or squeeze due to its low float, while others caution about it being a high-risk pump-and-dump, referencing patterns often seen with similar foreign-based offerings.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials is a trending topic following its recent IPO, with community discussion centered on its extremely low float of 1.25 million shares and a 180-day insider lock-up period, creating a strong short squeeze narrative. Many investors are anticipating significant price action, driven by recent patent news for its GelrinC product and expectations for further company updates.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

Structure Therapeutics (GPCR) is trending after releasing positive Phase 2b data for its oral GLP-1 receptor agonist, aleniglipron, demonstrating significant weight loss. The community is buzzing with speculation about a potential acquisition, especially given recent M&A activity in the competitive obesity drug sector. Investors are weighing the drug's efficacy and tolerability profile against rival therapies as a potential takeover target.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amid significant market volatility following its $7.75 billion all-cash acquisition of cybersecurity firm Armis and a notable analyst downgrade, intensifying concerns about AI's impact on the broader software sector. The stock has seen a sharp decline, leading to widespread community debate; many are frustrated by the persistent sell-off, while others view the current valuation as a compelling long-term buying opportunity for a high-quality company strategically positioned to integrate AI. Investors are actively discussing whether the market is overreacting to disruption fears, overlooking ServiceNow's core strengths and its potential to leverage AI for future growth.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is a hot topic amidst significant debate surrounding the impact of ongoing stablecoin regulatory discussions, including the delayed Clarity Act, which has contributed to recent volatility. Despite these uncertainties, investors are actively 'buying the dip,' energized by strategic partnerships with Visa, Intuit, Bybit, and OCC approval for national trust bank charters. The community is weighing Circle's business model profitability in a changing interest rate environment against the accelerating institutional adoption and expanding ecosystem for its USDC stablecoin.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PAVmed Announces Reverse Stock Split

PAVmed Announces Reverse Stock Split PAVmed Announces Reverse Stock Split PR Newswire NEW YORK, Dec. 30, 2025 NEW YORK, Dec. 30, 2025 /PRNewswire/ --PAVmed Inc.(NASDAQ: PAVM) ('PAVmed' or the...

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection Lucid Diagnostics Announces Positive Data from the Largest Reported...

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree PR Newswire NEW YORK, Nov. 20, 2025...

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and...

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW YORK, Nov. 13, 2025...

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW...

PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 PR Newswire NEW YORK, Oct. 30, 2025...

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 PR Newswire...

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit PR Newswire NEW YORK, Oct. 15, 2025 NEW YORK, Oct. 15, 2025...

PAVmed (PAVM) Upgraded to Strong Buy: Here's Why

PAVmed (PAVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$8.75
Prev Close	$9.19
Open	$9.27
Dividend Yield	0.00%
50-Day Moving Average	$9.54
Beta	1.23
Avg. Volume	14,948.69
PE Ratio	-0.54

52-Week High	$26.85
52-Week Low	$6.00
Market Capitalization	$9.77M
EPS (Annual)	$14.88
Price to Book	0.84
Revenue Per Employee	$76,794.87
Enterprise Value/EBITDA	N/A

PAVM
PAVmed Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PAVM News

PAVMPAVmed Inc